Thanks to significant investments in R&D, MC Biotech has developed a series of innovative diagnostic tests, in which non-invasiveness and compliance for the patient are the guideline of the technological design.

With an interdisciplinary team, which brings together entrepreneurs from the biomedical sector, scientists and experts in point-of-care diagnostics, and partnerships with important research institutes and international companies (Italian Institute of Technology, University of Insubria, Macchi Foundation University Hospital of Varese , Eiken Chemical JP, Daos Group), MC Biotech is able to provide cutting-edge diagnostic solutions dedicated to personalized medicine, nutrigenomics, infectious disease diagnostics (including Covid-19), veterinary field, up to industrial quality control.

MC Biotech has several partnerships with international distributors and clients (eg, MSC Cruises) and is currently present in various countries with its diagnostic technologies.